NURSING MODEL--RESPIRATORY MUSCLE STRENGTH IN COPD
护理模型--慢阻肺患者的呼吸肌力量
基本信息
- 批准号:2655411
- 负责人:
- 金额:$ 41.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-02-10 至 2002-01-31
- 项目状态:已结题
- 来源:
- 关键词:body composition chronic obstructive pulmonary disease clinical research dyspneas functional ability human subject longitudinal human study model design /development muscle strength nursing models outcomes research photon absorptiometry respiratory airflow measurement respiratory gas respiratory infections respiratory muscles
项目摘要
Patients with chronic obstructive pulmonary disease (COPD) demonstrate
a reduced functional strength of the inspiratory muscles which places
them at risk for the development of respiratory muscle fatigue and
ventilatory failure and contributes to sensations of dyspnea and
ultimately to a decrease in functional performance. This study will be
a longitudinal study with 10 years of follow-up, but the work described
here covers the first five years of the study and reflects the first 3
years of follow-up. The specific aims of this study are: (1) to describe
the deterioration in inspiratory muscle strength over the natural course
of the disease, (2) to examine the relationship between deterioration
inspiratory muscle strength, hyperinflation of the chest and loss of
muscle mass, (3) to describe the outcomes of deterioration in inspiratory
muscle strength with respect to dyspnea and functional performance and
(4) to describe the long-term effects of exacerbations with respect to
inspiratory muscle strength, peripheral muscle strength and muscle mass.
This study will include 100 patients with moderate to severe COPD and 50
healthy subjects. All variables will be measured four times, at baseline
and annually for three years. A subset of variables will be measured
after recovery from each exacerbation and/or respiratory tract infection
(RTI). Major variables include: (l) inspiratory muscle strength measured
as the maximal inspiratory pressure, (2) hyperinflation defined as the
ratio of the residual volume to total lung capacity, (3) body composition
measured with dual energy x-ray absorptiometry, skinfold thicknesses and
mid-arm muscle area, (4) peripheral muscle strength of the knee
flexors/extensors and hand grip, (5) dyspnea with the Chronic Respiratory
Disease Questionnaire, (6) functional performance with the 12 minute
distance walk, Functional Performance Inventory and the Sickness Impact
Profile. The first four variables will be measured after recovery from
each exacerbation/RTI. Data will be analyzed with descriptive statistics
and repeated measures ANOVA.
慢性阻塞性肺疾病(COPD)患者表现出
吸气肌的功能强度降低,
他们有发生呼吸肌疲劳的风险,
呼吸衰竭,并导致呼吸困难的感觉,
最终导致功能性能下降。本研究将
一项为期10年的纵向研究,但这项工作描述了
这里涵盖了研究的前五年,并反映了前三年
多年的后续。本研究的具体目的是:(1)描述
在自然过程中吸气肌肉力量的退化
(2)检查病情恶化与
吸气肌肉力量,胸部过度充气和
肌肉质量,(3)描述吸气功能恶化的结果
与呼吸困难和功能表现有关的肌肉力量,
(4)描述急性加重对以下方面的长期影响
吸气肌力、外周肌力和肌肉质量。
本研究将纳入100例中度至重度COPD患者和50例
例正常人所有变量将在基线时测量4次
每年一次,持续三年。将测量变量的子集
每次急性加重和/或呼吸道感染恢复后
(RTI)。主要变量包括:(l)测量的吸气肌力
最大吸气压力,(2)过度充气,定义为
残气量与肺总容量的比值,(3)身体成分
用双能X线吸收法测量,皮褶厚度和
臂中肌面积;(4)膝关节周围肌力
屈肌/伸肌和握力,(5)慢性呼吸道疾病引起的呼吸困难
疾病问卷,(6)12分钟功能表现
远距离步行、功能性行为量表和疾病影响
Profile.前四个变量将在恢复后测量,
每次加重/RTI。将使用描述性统计分析数据
重复测量方差分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JANET L. LARSON其他文献
JANET L. LARSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JANET L. LARSON', 18)}}的其他基金
Center for Reducing Risks in Vulnerable Populations
降低弱势群体风险中心
- 批准号:
6793884 - 财政年份:2004
- 资助金额:
$ 41.87万 - 项目类别:
Center for Reducing Risks in Vulnerable Populations
降低弱势群体风险中心
- 批准号:
6949664 - 财政年份:2004
- 资助金额:
$ 41.87万 - 项目类别:
Center for Reducing Risks in Vulnerable Populations
降低弱势群体风险中心
- 批准号:
7121212 - 财政年份:2004
- 资助金额:
$ 41.87万 - 项目类别:
CENTER FOR RESEARCH ON CARDIOVASCULAR/RESPIRATORY HEALTH
心血管/呼吸系统健康研究中心
- 批准号:
6401198 - 财政年份:2001
- 资助金额:
$ 41.87万 - 项目类别:
CENTER FOR RESEARCH ON CARDIOVASCULAR AND RESPIRATORY HE
心血管和呼吸研究中心
- 批准号:
6529361 - 财政年份:2001
- 资助金额:
$ 41.87万 - 项目类别:
相似海外基金
ARE COMMONLY USED CARDIOVASCULAR RISK SCORING TOOLS RELIABLE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)?
常用的心血管风险评分工具对于慢性阻塞性肺疾病 (COPD) 患者可靠吗?
- 批准号:
493118 - 财政年份:2023
- 资助金额:
$ 41.87万 - 项目类别:
Decoding how the aryl hydrocarbon receptor (AhR) controls cigarette smoke-induced lung inflammation and development of chronic obstructive pulmonary disease (COPD)
解读芳烃受体 (AhR) 如何控制香烟烟雾引起的肺部炎症和慢性阻塞性肺病 (COPD) 的发展
- 批准号:
487508 - 财政年份:2023
- 资助金额:
$ 41.87万 - 项目类别:
Operating Grants
The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
- 批准号:
10633608 - 财政年份:2023
- 资助金额:
$ 41.87万 - 项目类别:
Optimisation of precision therapy for chronic obstructive pulmonary disease: A dynamic treatment regime analysis
慢性阻塞性肺疾病精准治疗优化:动态治疗方案分析
- 批准号:
489950 - 财政年份:2023
- 资助金额:
$ 41.87万 - 项目类别:
Operating Grants
Elucidation of the mechanism of sarcopenia associated with chronic obstructive pulmonary disease
阐明肌肉减少症与慢性阻塞性肺疾病相关的机制
- 批准号:
23K15702 - 财政年份:2023
- 资助金额:
$ 41.87万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Risk factors for chronic obstructive pulmonary disease exacerbations, quality of care, and outcomes in people with HIV
HIV 感染者慢性阻塞性肺病恶化的危险因素、护理质量和结果
- 批准号:
10700228 - 财政年份:2023
- 资助金额:
$ 41.87万 - 项目类别:
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease
肺炎球菌抗体功能受损和慢性阻塞性肺疾病恶化
- 批准号:
10543560 - 财政年份:2022
- 资助金额:
$ 41.87万 - 项目类别:
Pulmonary Vascular Disease as a Contributor to Respiratory Morbidity in Chronic Obstructive Pulmonary Disease
肺血管疾病是慢性阻塞性肺疾病呼吸系统疾病发病的一个原因
- 批准号:
10449417 - 财政年份:2022
- 资助金额:
$ 41.87万 - 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations_Supplement
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测_补充
- 批准号:
10772527 - 财政年份:2022
- 资助金额:
$ 41.87万 - 项目类别:
Fungal Translocation in Chronic Obstructive Pulmonary Disease
慢性阻塞性肺疾病中的真菌移位
- 批准号:
10610446 - 财政年份:2022
- 资助金额:
$ 41.87万 - 项目类别: